Avadel Pharmaceuticals (AVDL) is undervalued, with $2B+ sales potential and key catalysts ahead. Read here for more analysis.

Global pharma stocks slipped Friday after President Donald Trump unveiled one of his toughest trade moves yet: a 100% tariff ...

On Thursday, the European Commission cleared its Alzheimer's drug Kisunla (donanemab) for use in adults in the earliest ...

The music mogul’s lawyers said in a filing that their incarcerated client deserves to be let go soon after his Oct. 3 ...

In this continuation of a three-part series, the author explores the potential use of agentic AI in pharmaceutical R&D.

CRAZY OVER KRATOM: The Trump administration has moved to clamp down on 7-hydroxymitragynine, a derivative of the increasingly popular herbal supplement kratom, and industry groups representing kratom ...

In a long-awaited and much-dreaded announcement on Monday evening, President Donald Trump and Health and Human Services ...

Vertex faces pressure from potential U.S. drug pricing reforms and tariffs. Click here to find out why VRTX stock is a Hold.

Your first Medicare bill could be a lot more than you were expecting. Here’s how to prepare for a bill that could run into ...

When we invest, we're generally looking for stocks that outperform the market average. Buying under-rated businesses ...

President Trump had intensified pressure on the Justice Department in recent days, publicly demanding that top officials ...

The “zero-calorie” PAM cooking spray in your pantry might be quietly adding pounds to your waistline. If that sounds ...